• Research and Development

  When Treating Rare Disease Patients, Don’t Overlook Quality of Life, Panel Urges

  Posted by Pulmonary Fibrosis News Moderator on June 1, 2018 at 12:50 pm

  Read why emerging therapies for pulmonary fibrosis, and how they impact patient quality of life, have researchers and pharmaceutical companies asking, “Is it worth investing in?”: #ERDC2018 – When Treating Rare Disease Patients, Don’t Overlook Quality of Life, Panel Urges

  How have the treatments you tried impacted your quality of life? On a scale of 1-10, how important is quality of life to you, versus treatment effectiveness?

  replied 6 years, 6 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply